Biotech

All Articles

Oncternal equity drains 60% amid cutbacks, test discontinuations

.Cancer business Oncternal Rehabs is folding all its clinical trials and giving up personnel, transf...

Roche is carrying out chances that its injectable obesity possibility might at some point show 25% fat burning in late-stage trial

.Roche is actually storing out hopes that its own injectable weight problems prospect can inevitably...

Novo Nordisk barrages 'remarkable' effective weight loss lead for dual-acting dental drug in very early test

.Novo Nordisk has actually lifted the top on a period 1 trial of its oral amylin as well as GLP-1 re...

AbbVie files a claim against BeiGene over blood cancer medication trade secrets

.Merely a few short full weeks after succeeding an FDA Fast Track tag for its own investigational BT...

Lilly provides one-two punch with second tranche of favorable data on regular the hormone insulin prospect

.Quickly after a positive data reduce for Eli Lilly's efsitora alfa, the Indianapolis-based company ...

BridgeBio reduces genetics therapy finances as clinical information disappoint

.BridgeBio Pharma is actually slashing its genetics therapy budget as well as pulling back from the ...

GSK relinquishes HSV vaccine hopes after period 2 fall short, delivering ethnicity to Moderna, BioNTech

.GSK's effort to create the very first vaccine for herpes simplex virus (HSV) has finished in failin...

GSK's long-acting asthma medicine cut in half strikes in stage 3

.GSK's long-acting breathing problem treatment has actually been actually presented to cut in half t...

AstraZeneca, Daiichi unbox Dato-DXd's total survival fail

.AstraZeneca and Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) has actually stopped ...

Roivant unveils brand-new 'vant' to advance Bayer high blood pressure med

.Matt Gline is back with a brand-new 'vant' firm, after the Roivant Sciences CEO paid Bayer $14 thou...